{
    "nctId": "NCT05651087",
    "briefTitle": "Evaluate Efficacy and Safety of LACUDY for Improving Vaginal Environment in Breast Cancer Patient",
    "officialTitle": "A Randomized Prospective Clinical Trial to Evaluate Efficacy and Safety of LACUDY for Improving Vaginal Environment Among Breast Cancer Survivals Who Receive Anti-estrogen Therapy",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Hormone Receptor-positive Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Change of Vaginal health index",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female\n2. Aged 20 to 60 years diagnosed with breast cancer\n3. Receiving anti-hormonal therapy\n4. Patients who subjectively complain of vaginal dryness\n5. Patients without current psychiatric problems\n6. Patients who can understand and respond to the contents of the questionnaire\n7. Ability to provide informed consent\n\nExclusion Criteria:\n\n1. Women under 19 and over 61\n2. Pregnant woman\n3. In case of recurrence or disease progression\n4. Patients without sexual experience\n5. Unable to provide informed consent",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT"
}